fda semaglutide shortage resolved february 2025 announcement Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA: Ozempic and Wegovy drug

Led by scientists from the United States, Brazil, Iran, and Israel, the study highlights that while GLP-1 receptor agonists can be beneficial for individuals with hyperdopaminergia (elevated dopamine activity), they may have adverse effects on those with hypodopaminergia (reduced dopamine function)

GLP-1 in addiction medicine: GLP-1 acts on pancreas, gut, kidney, heart and thyroid receptors to activate reward/stress hubs (VTA, NAc, ARC, PFC, hypothalamus)

Forums may offer insights, but safe, legal pathways are the only reliable option

Salicylic Acid (1 ppm) Mild exfoliation

This figure is subject to annual MPFS updates and the GPCI adjustment for your locality